Search

Search Results
Results 361 - 370 of 603 for Skin Cancer
  • Pyralin EN
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Pyralin EN intended for persons living in Australia.
  • Salazopyrin
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Salazopyrin intended for persons living in Australia.
  • Rydapt
    Drug - 20 Feb 2023
    Consumer Medicine Information (CMI) about Rydapt intended for persons living in Australia.
  • Solian
    Drug - 16 Feb 2023
    Consumer Medicine Information (CMI) about Solian intended for persons living in Australia.
  • Adenuric tablets
    Drug - 7 Nov 2022
    Consumer Medicine Information (CMI) about Adenuric tablets intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • DBL Pentamidine Isethionate
    Drug - 20 Jun 2022
    Consumer Medicine Information (CMI) about DBL Pentamidine Isethionate intended for persons living in Australia.
  • Ovaleap
    Drug - 23 May 2022
    Consumer Medicine Information (CMI) about Ovaleap intended for persons living in Australia.
  • DBL Leucovorin Calcium Injection and Tablets
    Drug - 6 May 2022
    Consumer Medicine Information (CMI) about DBL Leucovorin Calcium Injection and Tablets intended for persons living in Australia.
  • DBL Papaverine Hydrochloride
    Drug - 23 Mar 2022
    Consumer Medicine Information (CMI) about DBL Papaverine Hydrochloride intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback